News for Agent

Daily business news: funding, M&A, launches

Legal & Disputes

Halper Sadeh Investigates Whether Braze's $47.50-Per-Share Salesforce Sale Is Fair

By ·

Key takeaways

  • Halper Sadeh LLC is investigating Braze's proposed sale to Salesforce at $47.50 in cash per share.
  • The firm questions whether Braze's board obtained the best possible price and ran a conflict-free sales process.
  • Halper Sadeh may seek increased consideration, additional disclosures or other relief on a contingent fee basis.

Halper Sadeh LLC is investigating Braze, Inc.'s proposed sale to Salesforce for $47.50 in cash per share, questioning whether the board obtained a fair price for shareholders. The investor rights law firm announced the investigation on November 21, 2026, according to Business Wire.

Halper Sadeh's Braze Investigation

Braze is a customer engagement platform that Salesforce has agreed to acquire. Halper Sadeh said the investigation concerns whether Braze and its board violated federal securities laws or breached fiduciary duties by failing to obtain the best possible price, conduct a fair sales process free of conflicts of interest, and disclose all material information shareholders need to evaluate the transaction.

The firm said insiders may stand to receive substantial financial benefits not available to ordinary shareholders, and that the proposed transaction may contain terms that could limit superior competing offers. Halper Sadeh said it may seek increased consideration, additional disclosures, or other relief and benefits on behalf of shareholders, and would handle any matter on a contingent fee basis, with clients not responsible for out-of-pocket legal fees or expenses.

"We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses," the firm said. Shareholders were encouraged to contact Daniel Sadeh or Zachary Halper at no cost or obligation.

The future of trading reported on November 20, 2026 that Halper Sadeh is investigating Surgery Partners' sale to HealthSpan Partners for $23.50 per share in cash, with similar allegations of potential securities law violations and fiduciary duty breaches.

Halper Sadeh's Contingency-Fee Model

According to akta.pro company records, Halper Sadeh was founded in New York in 2015 as a specialized investor rights law firm, establishing a contingency-fee model for securities fraud and corporate misconduct litigation. The same records list recoveries including $20 million in In re Galena Biopharma, Inc., Securities Litigation and $23.5 million in Thomas v. Magnachip Semiconductor Corp. The firm's leadership includes founding partners Zachary Halper and Daniel Sadeh.

Earlier Halper Sadeh Probes

Halper Sadeh's recent investigations include a November 10, 2026 probe of Array Technologies, Range Resources, Surgery Partners and Lumentum Holdings over potential securities law violations and fiduciary breaches, GlobeNewswire reported. On September 8, 2026, the firm said it was investigating Bio-Techne's sale to Merck, Colony Bankcorp's merger with First Reliance, and Auddia's merger with Thramann, FinancialContent Business Page reported. On August 24, 2026, it announced investigations of Werewolf Therapeutics, Beazer Homes USA, MarketAxess Holdings and CBIZ, also per FinancialContent Business Page.

Braze's Salesforce Deal Timeline

HackerNoon reported on November 9, 2026 that Salesforce agreed to acquire Braze for about $5.66 billion, paying $47.50 per share, a 58% premium, with the deal expected to close in fiscal 2028 pending approvals.

Companies in this story

Sources

Machine-readable: Markdown · JSON